N
Nuoer Medical
Specialty polymer manufacturer for diverse industrial applications
About Nuoer Medical
Shandong Nuoer Biological Technology Co., Ltd., part of the Nuoer Group, is a high-tech enterprise established in 2011 specializing in the research, development, production, and marketing of water-soluble polymers. The company's core products include super absorbent polymers (SAP), polyacrylamide (PAM), acrylic acid, and acrylamide. These materials are utilized across various industries such as water treatment, paper making, mineral processing, and oil extraction. Additionally, their super absorbent polymers are key components in personal hygiene products like diapers and sanitary napkins.
Based in Dongying, Shandong Province, China, the company operates a large industrial park and has a significant production capacity, with an annual output of hundreds of thousands of tons across its main product lines. Nuoer serves a global market, exporting to over 60 countries and regions. Its business model is centered on the large-scale manufacturing and direct sales of its chemical products to industrial clients, supported by a global sales network and after-sales service system. The company's client roster includes major international corporations like BHP Billiton and Anglo American.
The Nuoer Group, which includes Shandong Nuoer Bio-Tech, was originally founded as Dongying Nuoer Chemical Co., Ltd. in 1997. The company has a strong focus on research and development, maintaining collaborations with several universities, including Shandong University and Qingdao University of Science and Technology, and holds numerous patents. This has led to the development of advanced products, some of which have been included in the National Torch Program, a Chinese initiative to promote high-tech industries.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2022 | $14M | $55M | Shenzhen High-tech Investment · Tongwei Group · Sunland fund | ↗ |
Growth signals
Latest recorded traffic for Nuoer Medical is 200 monthly website visits, down 58.3% over the last three months. Nuoer Medical's team grew 13.9% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Nuoer Medical in the Naples ecosystem
The Nuoer Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- SIShenzhen High-tech Investment
Tongwei Group
Sunland fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nuoer Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nuoer Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.